MedTrace Logo

Comparative Analysis of Different Tests to Evaluate Prognosis of Patients on Liver Transplant Waiting List

NCT01774617 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-10-09

No results posted yet for this study

Summary

It is a cohort to evaluate the power of different diagnostic tests in predicting the prognosis of patients with severe liver disease.

Patients with decompensated liver cirrhosis on the waiting list for liver transplantation will be evaluated with comparison of different diagnostic tests according to the MELD score (Model for End-Stage Liver Disease), MELD-Na (Model for End-Stage Liver Disease and sodium), indocyanine green clearance test, hepatic venous pressure gradient and transient elastography. All patients will be submitted to all the tests and prospectively followed for 6 months, to establish mortality and complications related to liver disease in order to define the value of each method to predict outcomes.

Conditions

  • Cirrhosis
  • Liver Failure
  • Portal Hypertension

Sponsors & Collaborators

  • Rio de Janeiro State Research Supporting Foundation (FAPERJ)

    collaborator OTHER_GOV

  • Guilherme Rezende

    lead OTHER

Principal Investigators

  • Guilherme FM Rezende, MD PhD · Universidade Federal do Rio de Janeiro

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01774617 on ClinicalTrials.gov